Category: Minimal/Measurable Residual Disease
Testing for minimal or measurable residual disease (MRD) in blood cancer has transformed the way we look at remission and […]
Have you ever wondered how doctors determine the treatment for a blood cancer patient? In this episode, we’re speaking with […]
Join us as we speak to Dr. Lori Muffly and Dr. Matthew Frank from Stanford Medicine in Stanford, CA, about […]